牛叉诊股

[{"date":"2026.04.27","stock":"0.42","trade":"-0.06","ind":"0.37"},{"date":"2026.04.24","stock":"-2.58","trade":"0.07","ind":"-0.69"},{"date":"2026.04.23","stock":"-1.58","trade":"-1.89","ind":"-0.88"},{"date":"2026.04.22","stock":"2.18","trade":"1.12","ind":"1.30"},{"date":"2026.04.21","stock":"-1.53","trade":"-1.11","ind":"0.10"},{"date":"2026.04.20","stock":"2.41","trade":"0.69","ind":"0.55"},{"date":"2026.04.17","stock":"-0.31","trade":"-1.80","ind":"0.60"},{"date":"2026.04.16","stock":"1.43","trade":"-0.04","ind":"2.05"},{"date":"2026.04.15","stock":"0.00","trade":"0.14","ind":"-0.97"},{"date":"2026.04.14","stock":"2.22","trade":"1.73","ind":"1.61"},{"date":"2026.04.13","stock":"-1.44","trade":"-1.22","ind":"0.69"},{"date":"2026.04.10","stock":"0.43","trade":"0.70","ind":"2.24"},{"date":"2026.04.09","stock":"-4.99","trade":"-1.86","ind":"-0.33"},{"date":"2026.04.08","stock":"6.74","trade":"2.51","ind":"4.79"},{"date":"2026.04.07","stock":"1.15","trade":"0.66","ind":"0.36"},{"date":"2026.04.03","stock":"-3.24","trade":"-3.06","ind":"-0.99"},{"date":"2026.04.02","stock":"-2.03","trade":"-0.64","ind":"-1.60"},{"date":"2026.04.01","stock":"4.01","trade":"5.25","ind":"1.70"},{"date":"2026.03.31","stock":"-1.49","trade":"0.22","ind":"-1.81"},{"date":"2026.03.30","stock":"1.30","trade":"1.19","ind":"-0.25"},{"date":"2026.03.27","stock":"2.78","trade":"4.12","ind":"1.13"}]

迪安诊断,深证成指,医疗服务指数

压力支撑

该股压力位为18.74元，支撑位为18.32元。

[{"text":"\u538b\u529b\u4f4d","value":"18.74","date":1777219200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.32","date":1777219200,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.4资金面打败了11%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：04月27日 20:30

机构今日流向(万元)	-1042.95	机构5日流向(万元)	-4874.33
机构10日流向(万元)	-8377.55	机构20日流向(万元)	-11366.26

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1092.97万股，其中基金净增仓7家，主力净增仓42家，请投资者中长期谨慎为宜。

截止2025-12-31，共156家主力机构（基金152家，QFII2家，一般法人2家），持仓量总计6264.38万股，占流通A股12.49%
其中，基金持仓与2025-06-30相比：
增仓：37家，增持 648.01万股
减仓：30家，减持 444.85万股
新出现在主力名单中：79家，持有802.42万股
从主力名单中消失：37家，原持有1853.96万股

消息面诊股

诊断结果：6.2消息面打败了67%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-04-22
利好	分红转增	10派3.5元(含税)	2026-04-22
一般消息	重大事项	关联交易	2026-04-22
一般消息	重大事项	公司股东股份解押	2026-01-28
利好	业绩预告	预计扭亏	2026-01-26
一般消息	重大事项	公司股东股份解押	2026-01-05
一般消息	高管变动	取消监事会	2025-12-31
一般消息	重大事项	公司股东股份解押	2025-12-05
一般消息	重大事项	公司股东股份解押	2025-11-03
一般消息	高管变动	因公司内部岗位调整	2025-10-13
一般消息	高管变动	因个人原因	2025-09-30
一般消息	分红转增	不分配不转增	2025-08-21
一般消息	重大事项	公司股东股份解押	2025-08-20
一般消息	重大事项	公司股东股份解押	2025-07-10
一般消息	重大事项	公司股东股份解押	2025-06-27

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：5.9行业面打败了72%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.04.27","price":"0.37","value":"-0.06"},{"date":"2026.04.24","price":"-0.69","value":"0.07"},{"date":"2026.04.23","price":"-0.88","value":"-1.89"},{"date":"2026.04.22","price":"1.30","value":"1.12"},{"date":"2026.04.21","price":"0.10","value":"-1.11"},{"date":"2026.04.20","price":"0.55","value":"0.69"},{"date":"2026.04.17","price":"0.60","value":"-1.80"},{"date":"2026.04.16","price":"2.05","value":"-0.04"},{"date":"2026.04.15","price":"-0.97","value":"0.14"},{"date":"2026.04.14","price":"1.61","value":"1.73"},{"date":"2026.04.13","price":"0.69","value":"-1.22"},{"date":"2026.04.10","price":"2.24","value":"0.70"},{"date":"2026.04.09","price":"-0.33","value":"-1.86"},{"date":"2026.04.08","price":"4.79","value":"2.51"},{"date":"2026.04.07","price":"0.36","value":"0.66"},{"date":"2026.04.03","price":"-0.99","value":"-3.06"},{"date":"2026.04.02","price":"-1.60","value":"-0.64"},{"date":"2026.04.01","price":"1.70","value":"5.25"},{"date":"2026.03.31","price":"-1.81","value":"0.22"},{"date":"2026.03.30","price":"-0.25","value":"1.19"},{"date":"2026.03.27","price":"1.13","value":"4.12"}]

深证成指,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	药康生物	33.29%	2.58%	6.6分
2	普瑞眼科	24.59%	8.42%	6.3分
3	昭衍新药	23.12%	-1.14%	5.5分
4	凯莱英	17.84%	3.52%	5.5分
5	美迪西	16.35%	0.13%	6.4分
6	泓博医药	16.26%	4.46%	5.6分
7	爱尔眼科	13.33%	12.51%	6.0分
8	百诚医药	12.01%	2.24%	5.9分
9	奥浦迈	11.68%	-9.94%	5.1分
10	康龙化成	10.97%	-4.12%	4.8分
11	博济医药	10.73%	4.17%	5.6分
12	金域医学	9.56%	1.95%	5.9分
13	诺思格	9.40%	-0.95%	6.4分
14	药石科技	8.34%	0.10%	5.3分
15	益诺思	7.44%	5.35%	6.0分
16	成都先导	6.87%	-0.97%	5.8分
17	泰格医药	6.38%	-3.09%	6.7分
18	百奥赛图	6.26%	0.81%	6.6分
19	华厦眼科	5.70%	3.55%	6.2分
20	诺禾致源	5.58%	0.62%	5.7分
21	博腾股份	4.90%	-2.77%	4.9分
22	皓元医药	4.58%	-6.20%	5.2分
23	药明康德	3.63%	0.76%	6.2分
24	华大基因	2.97%	2.13%	5.1分
25	迪安诊断	2.43%	-3.12%	5.7分
26	何氏眼科	2.41%	4.01%	6.4分
27	华康洁净	2.35%	-3.17%	4.9分
28	睿智医药	2.24%	-6.08%	5.1分
29	通策医疗	1.79%	3.92%	6.1分
30	万邦医药	1.69%	-5.15%	4.6分
31	和元生物	1.62%	-3.36%	4.8分
32	毕得医药	0.73%	-9.12%	4.9分
33	南模生物	0.46%	-4.64%	5.4分
34	普蕊斯	0.18%	-3.19%	5.3分
35	ST中珠	-0.36%	-6.16%	4.1分
36	*ST生物	-2.88%	1.56%	5.0分
37	三博脑科	-3.14%	-6.83%	4.2分
38	大东方	-3.53%	0.00%	4.6分
39	兰卫医学	-4.61%	-2.96%	5.4分
40	光正眼科	-4.72%	3.67%	6.2分
41	贝瑞基因	-5.28%	-3.62%	5.0分
42	-	-5.46%	-12.30%	分
43	皓宸医疗	-6.16%	1.57%	4.8分
44	百花医药	-6.60%	-5.67%	4.5分
45	创新医疗	-7.17%	-9.76%	4.6分
46	大湖股份	-7.23%	-3.90%	5.0分
47	澳洋健康	-7.60%	-1.57%	5.7分
48	海特生物	-7.60%	5.78%	5.6分
49	美年健康	-8.30%	-3.71%	5.4分
50	盈康生命	-9.18%	-5.48%	5.1分
51	新里程	-10.08%	-1.69%	5.4分
52	阳光诺和	-10.45%	-8.09%	4.6分
53	国际医学	-10.83%	-0.65%	4.7分
54	诚达药业	-13.08%	-4.41%	4.3分
55	金凯生科	-14.35%	-17.45%	4.4分
56	九洲药业	-15.49%	-17.33%	4.6分

<上一页 1 2 3 4 5...10 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
安信证券	2012-09-04	增持	增持
长江证券	2012-09-02	增持	-

基本面诊股

诊断结果：6.1基本面打败了62%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（25分）

基本面得分最高的股票

[ 截止日期：2025-12-31 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 30/103 ， 28/103。

[{"date":"2025-12-31","value":"0.68","vol":"3.15"},{"date":"2025-09-30","value":"0.87","vol":"3.24"},{"date":"2025-06-30","value":"0.16","vol":"2.24"},{"date":"2025-03-31","value":"-0.32","vol":"0.90"},{"date":"2024-12-31","value":"-5.06","vol":"-0.21"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
净资产收益率(%)	0.68	0.87	0.16	-0.32	-5.06
行业(%)	3.15	3.24	2.24	0.90	-0.21

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"28.47","vol":"34.02"},{"date":"2025-09-30","value":"29.07","vol":"36.06"},{"date":"2025-06-30","value":"27.59","vol":"36.21"},{"date":"2025-03-31","value":"26.39","vol":"34.35"},{"date":"2024-12-31","value":"28.01","vol":"34.98"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
销售毛利率(%)	28.47	29.07	27.59	26.39	28.01
行业(%)	34.02	36.06	36.21	34.35	34.98

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 39/103 ， 8/103。

[{"date":"2025-12-31","value":"-17.22","vol":"5.32"},{"date":"2025-09-30","value":"-18.28","vol":"3.06"},{"date":"2025-06-30","value":"-20.61","vol":"2.87"},{"date":"2025-03-31","value":"-20.45","vol":"-0.74"},{"date":"2024-12-31","value":"-9.04","vol":"-0.20"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
营业收入同比增长率(%)	-17.22	-18.28	-20.61	-20.45	-9.04
行业(%)	5.32	3.06	2.87	-0.74	-0.20

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"112.33","vol":"20.89"},{"date":"2025-09-30","value":"-56.67","vol":"20.05"},{"date":"2025-06-30","value":"-85.68","vol":"-63.31"},{"date":"2025-03-31","value":"-190.66","vol":"-22.48"},{"date":"2024-12-31","value":"-216.20","vol":"-105.42"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
净利润同比增长率(%)	112.33	-56.67	-85.68	-190.66	-216.20
行业(%)	20.89	20.05	-63.31	-22.48	-105.42

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 3/103 ， 21/103。

[{"date":"2025-12-31","value":"0.67","vol":"0.43"},{"date":"2025-09-30","value":"0.50","vol":"0.32"},{"date":"2025-06-30","value":"0.32","vol":"0.21"},{"date":"2025-03-31","value":"0.15","vol":"0.10"},{"date":"2024-12-31","value":"0.72","vol":"0.42"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
总资产周转率(次)	0.67	0.50	0.32	0.15	0.72
行业(次)	0.43	0.32	0.21	0.10	0.42

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"4.54","vol":"16.55"},{"date":"2025-09-30","value":"3.38","vol":"10.95"},{"date":"2025-06-30","value":"2.19","vol":"7.15"},{"date":"2025-03-31","value":"1.07","vol":"3.69"},{"date":"2024-12-31","value":"5.59","vol":"15.73"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
存货增长率(次)	4.54	3.38	2.19	1.07	5.59
行业(次)	16.55	10.95	7.15	3.69	15.73

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 5/103 ， 7/103。

[{"date":"2025-12-31","value":"45.71","vol":"20.96"},{"date":"2025-09-30","value":"22.59","vol":"16.52"},{"date":"2025-06-30","value":"17.38","vol":"15.83"},{"date":"2025-03-31","value":"-7.15","vol":"-1.06"},{"date":"2024-12-31","value":"39.25","vol":"22.16"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
现金流量净额/营业收入	45.71	22.59	17.38	-7.15	39.25
行业	20.96	16.52	15.83	-1.06	22.16

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"0.50","vol":"0.93"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.49","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.50","vol":"1.25"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
资本支出／折旧和摊销	0.50	-	0.49	-	0.50
行业	0.93	0.01	0.91	0.00	1.25

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/103 ， 26/103。

[{"date":"2025-12-31","value":"2.66","vol":"3.88"},{"date":"2025-09-30","value":"2.74","vol":"3.67"},{"date":"2025-06-30","value":"2.68","vol":"3.57"},{"date":"2025-03-31","value":"2.65","vol":"3.75"},{"date":"2024-12-31","value":"2.54","vol":"3.58"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
流动比率	2.66	2.74	2.68	2.65	2.54
行业	3.88	3.67	3.57	3.75	3.58

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"2.17","vol":"3.16"},{"date":"2025-09-30","value":"2.22","vol":"2.94"},{"date":"2025-06-30","value":"2.15","vol":"2.87"},{"date":"2025-03-31","value":"2.16","vol":"3.03"},{"date":"2024-12-31","value":"2.08","vol":"2.89"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
速动比率	2.17	2.22	2.15	2.16	2.08
行业	3.16	2.94	2.87	3.03	2.89

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 7/103 ， 8/103。

[{"date":"2025-12-31","value":"40.34","vol":"31.76"},{"date":"2025-09-30","value":"41.25","vol":"32.60"},{"date":"2025-06-30","value":"43.01","vol":"33.58"},{"date":"2025-03-31","value":"42.54","vol":"32.64"},{"date":"2024-12-31","value":"44.46","vol":"33.31"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
资产负债率(%)	40.34	41.25	43.01	42.54	44.46
行业(%)	31.76	32.60	33.58	32.64	33.31

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"0.90","vol":"0.98"},{"date":"2025-09-30","value":"0.94","vol":"0.92"},{"date":"2025-06-30","value":"1.01","vol":"0.96"},{"date":"2025-03-31","value":"0.99","vol":"0.97"},{"date":"2024-12-31","value":"1.07","vol":"1.03"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
产权比率 (%)	0.90	0.94	1.01	0.99	1.07
行业(%)	0.98	0.92	0.96	0.97	1.03

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
中泰证券	2026-04-22	买入
中国银河	2026-04-22	买入
东吴证券	2026-03-30	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"14.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.07","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-3.57","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.44","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"4.77","blueLineValue":"0.76","type":"YC"}]

[迪安诊断]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]